101 related articles for article (PubMed ID: 23268013)
21. Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III.
Hara M; Sato M; Takahashi H; Takayama S; Takeyama H
J Surg Oncol; 2010 Aug; 102(2):154-7. PubMed ID: 20648586
[TBL] [Abstract][Full Text] [Related]
22. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer.
Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S
Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of perioperative change of CEA level in colorectal patients when pre-operative level is normal.
Lan YT; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Yang SH
Hepatogastroenterology; 2012 May; 59(115):717-20. PubMed ID: 22024225
[TBL] [Abstract][Full Text] [Related]
25. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
[TBL] [Abstract][Full Text] [Related]
26. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
Eskelinen M; Pasanen P; Kulju A; Janatuinen E; Miettinen P; Poikolainen E; Tarvainen R; Nuutinen P; Pääkkönen M; Alhava E
Anticancer Res; 1994; 14(3B):1427-32. PubMed ID: 8067718
[TBL] [Abstract][Full Text] [Related]
28. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
29. [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer].
Sandelewski A; Kokocińska D; Partyka R; Kocot J; Starzewski J; Chanek I; Jałowiecki P
Pol Merkur Lekarski; 2005 Jun; 18(108):647-50. PubMed ID: 16124375
[TBL] [Abstract][Full Text] [Related]
30. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
[TBL] [Abstract][Full Text] [Related]
31. The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patients.
Sandler B; Smirnoff P; Shani A; Idelevich E; Kaganski N; Pfefferman R; Davidovich B; Zusman I
Anticancer Res; 1999; 19(5B):4229-33. PubMed ID: 10628379
[TBL] [Abstract][Full Text] [Related]
32. Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients.
Choi JS; Min JS
Yonsei Med J; 1997 Feb; 38(1):1-7. PubMed ID: 9100477
[TBL] [Abstract][Full Text] [Related]
33. Serum p53 antibody is a useful tumor marker of early colorectal cancer.
Noaki R; Kawahara H; Watanabe K; Ushigome T; Kobayashi S; Yanaga K
Int Surg; 2010; 95(4):287-92. PubMed ID: 21309408
[TBL] [Abstract][Full Text] [Related]
34. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
Kos J; Nielsen HJ; Krasovec M; Christensen IJ; Cimerman N; Stephens RW; Brünner N
Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
[TBL] [Abstract][Full Text] [Related]
35. The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study.
Yüceyar S; Ertürk S; Dirican A; Cengiz A; Saner H
Int Surg; 1996; 81(2):136-9. PubMed ID: 8912078
[TBL] [Abstract][Full Text] [Related]
36. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
[TBL] [Abstract][Full Text] [Related]
37. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum CEA protein and CEA mRNA after resection of colorectal liver metastases.
Kijima M; Togo S; Ichikawa Y; Miura M; Yamagishi S; Matsuo K; Tanaka K; Masui H; Ishikawa T; Ike H; Shimada H
Anticancer Res; 2005; 25(2B):1327-32. PubMed ID: 15865086
[TBL] [Abstract][Full Text] [Related]
39. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
40. Expression of p53 and Ki-67 as prognostic factors for survival of men with colorectal cancer.
Lumachi F; Orlando R; Marino F; Chiara GB; Basso SM
Anticancer Res; 2012 Sep; 32(9):3965-7. PubMed ID: 22993345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
